First In-Man Experience Exceeds Expectations, Cited as “Game Changer” for Below-the-Knee Procedures CAMBRIDGE, Mass.--(BUSINESS WIRE)--Summa Therapeutics, LLC announced today that the first-in-man ...
Surgical and catheter ablation are both effective for the long-term reduction of persistent atrial fibrillation (AF) burden, according to 3-year data from the CASA-AF trial. The study also included a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results